Lexiang Zeng

543 total citations
19 papers, 440 citations indexed

About

Lexiang Zeng is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Lexiang Zeng has authored 19 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Lexiang Zeng's work include MicroRNA in disease regulation (4 papers), Liver physiology and pathology (3 papers) and RNA modifications and cancer (3 papers). Lexiang Zeng is often cited by papers focused on MicroRNA in disease regulation (4 papers), Liver physiology and pathology (3 papers) and RNA modifications and cancer (3 papers). Lexiang Zeng collaborates with scholars based in China and Macao. Lexiang Zeng's co-authors include Xiaogeng Deng, Hai Huang, Zhenghui Guo, Ganping Wang, Yiming Lai, Jiajia Zhou, Yi Cao, Jieqing Chen, Tao Du and Jie Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Medicine.

In The Last Decade

Lexiang Zeng

18 papers receiving 437 citations

Peers

Lexiang Zeng

REHAB

SURGE

ONCOL

Ali Asadirad Iran

Anjali Mittal United States

Gianmarco Villano Italy

Sarah Bühler Germany

Hidetaka Hosono Japan

Yuhan Yang China

Qingyang Gu China

Guoliang Wang China

Chengliang Zhao China

Hong Hu China

Ali Asadirad Iran

Lexiang Zeng

311 ×1.3

141 ×0.8

29 ×0.5

REHAB

44 ×0.7

SURGE

35 ×0.6

ONCOL

Citations per year, relative to Lexiang Zeng Lexiang Zeng (= 1×) peers Ali Asadirad

Countries citing papers authored by Lexiang Zeng

Since Specialization

Citations

This map shows the geographic impact of Lexiang Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lexiang Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexiang Zeng more than expected).

Fields of papers citing papers by Lexiang Zeng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lexiang Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lexiang Zeng. The network helps show where Lexiang Zeng may publish in the future.

Co-authorship network of co-authors of Lexiang Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Lexiang Zeng. A scholar is included among the top collaborators of Lexiang Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lexiang Zeng. Lexiang Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Li, Lingfeng, Bisheng Cheng, Yongming Chen, et al.. (2024). SERPINH1 modulates apoptosis by inhibiting P62 ubiquitination degradation to promote bone metastasis of prostate cancer. iScience. 27(8). 110427–110427. 3 indexed citations

Lai, Yiming, Wenhao Ouyang, Yunfang Yu, et al.. (2024). Integrative analysis of cuproptosis-related lncRNAs: Unveiling prognostic significance, immune microenvironment, and copper-induced mechanisms in prostate cancer. SHILAP Revista de lepidopterología. 3(1). 48–59. 4 indexed citations

Peng, Shengmeng, Jin Li, Zean Li, et al.. (2023). SALL4 correlates with proliferation, metastasis, and poor prognosis in prostate cancer by affecting MAPK pathway. Cancer Medicine. 12(12). 13471–13485. 10 indexed citations

Li, Guowei, et al.. (2023). Bacteria-Loaded Gastro-Retention Oral Delivery System for Alcohol Abuse. ACS Biomaterials Science & Engineering. 9(3). 1460–1471. 1 indexed citations

Li, Wenpeng, et al.. (2021). Development of a preoperative index-based nomogram for the prediction of hypokalemia in patients with pituitary adenoma: a retrospective cohort study. PeerJ. 9. e11650–e11650.

Zhang, Liming, Liqun Yang, Junfeng Wu, et al.. (2021). Sustained delivery of MMP-9 siRNA via thermosensitive hydrogel accelerates diabetic wound healing. Journal of Nanobiotechnology. 19(1). 130–130. 90 indexed citations

Zeng, Lexiang, et al.. (2021). Two-stage laparoscopic resection of giant hepatoblastoma in infants combined with liver partial partition and artery ligation. World Journal of Surgical Oncology. 19(1). 63–63. 7 indexed citations

Chen, Luping, et al.. (2020). CircRNA CDR1as promotes hepatoblastoma proliferation and stemness by acting as a miR-7-5p sponge to upregulate KLF4 expression. Aging. 12(19). 19233–19253. 34 indexed citations

Zeng, Lexiang, et al.. (2020). circFOXM1 contributes to sorafenib resistance of hepatocellular carcinoma cells by regulating MECP2 via miR-1324. Molecular Therapy — Nucleic Acids. 23. 811–820. 37 indexed citations

10.

Zeng, Lexiang, Liyang Liang, Jie Zhang, et al.. (2020). Effective surgical treatment of life-threatening huge vascular anomalies associated with thrombocytopenia and coagulopathy in infants unresponsive to drug therapy. BMC Pediatrics. 20(1). 187–187. 3 indexed citations

11.

Zeng, Lexiang, et al.. (2017). Analysis of treatment of large abdominal malignancies in children complicated with abdominal compartment syndrome. Medicine. 96(17). e6705–e6705. 4 indexed citations

12.

Jiang, Wenli, Wen Gu, Songbing He, et al.. (2016). miRNA-101 Suppresses Epithelial-to-mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells. Anti-Cancer Agents in Medicinal Chemistry. 16(4). 432–439. 22 indexed citations

13.

Jin, Li, Yiming Lai, Yi Cao, et al.. (2014). SHARPIN overexpression induces tumorigenesis in human prostate cancer LNCaP, DU145 and PC-3 cells via NF-κB/ERK/Akt signaling pathway. Medical Oncology. 32(2). 104–104. 80 indexed citations

14.

Zeng, Lexiang, et al.. (2014). Comparative Analysis of Modified Laparoscopic Swenson and Laparoscopic Soave Procedure for Short-Segment Hirschsprung Disease in Children. European Journal of Pediatric Surgery. 25(5). 430–434. 9 indexed citations

15.

Zhang, Yiming, Hai Huang, Huimin Zhou, et al.. (2014). Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer. Cancer. 120(20). 3208–3218. 41 indexed citations

16.

Deng, Xiaogeng, Zhixi Li, Ping Xie, et al.. (2013). Overexpression of miR‐122 promotes the hepatic differentiation and maturation of mouse ESCs through a miR‐122/FoxA1/HNF4a‐positive feedback loop. Liver International. 34(2). 281–295. 76 indexed citations

17.

Deng, Xiaogeng, Zhixi Li, Jie Zhang, et al.. (2012). Selection of Hepatocyte-Like Cells from Mouse Differentiated Embryonic Stem Cells and Application in Therapeutic Liver Repopulation. Cellular Physiology and Biochemistry. 30(5). 1271–1286. 3 indexed citations

18.

Deng, Xiaogeng, et al.. (2012). A modified laparoscopic splenectomy for massive splenomegaly in children with hematological disorder: a single institute retrospective clinical research. Pediatric Surgery International. 28(12). 1201–1209. 9 indexed citations

19.

Guo, Zhenghui, Hai Huang, Lexiang Zeng, et al.. (2010). Lentivirus-mediated RNAi knockdown of prostate-specific membrane antigen suppresses growth, reduces migration ability and the invasiveness of prostate cancer cells. Medical Oncology. 28(3). 878–887. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact